Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02877134 · ClinicalTrials.gov registry record · Phase 2

Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease

A Phase 2 study of Crohn Disease, sponsored by Janssen Research & Development.

Completed
Registry status
Phase 2
Development phase
388
Enrollment target
20
Study locations

NCT02877134 is a Phase 2 study of Crohn Disease that has completed, run by Janssen Research & Development. The registered enrollment target is 388 participants, above the 200-participant average among 71 other Crohn Disease trials with a reported enrollment target (94% higher). The trial reports 20 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02877134, a Phase 2 study of Crohn Disease, has completed, sponsored by Janssen Research & Development.

COMPLETED
Registry status
Phase 2
Development phase
388 participants
Enrollment target
20
Study locations

Study Summary

The purpose of the study is to assess the safety and efficacy of JNJ-64304500 in participants with moderately to severely active Crohn's disease.

Conditions Studied

Crohn Disease

Interventions

  • DRUG Placebo
  • DRUG Ustekinumab
  • DRUG JNJ-64304500

Study Locations (20)

Florida

  • - Coral Gables
  • - Kissimmee
  • - Miami
  • - Miramar
  • - Orlando
  • - Winter Park

New York

  • - Brooklyn
  • - Great Neck
  • - New York
  • - Rochester

Louisiana

  • - Houma
  • - Lake Charles
  • - Shreveport

Illinois

  • - Chicago
  • - Evanston

Colorado

  • - Lone Tree

Georgia

  • - Marietta

Indiana

  • - Indianapolis

Maryland

  • - Columbia

Trial Details

FieldValue
Enrollment Target 388 participants
Start Date 2016-08-25
Est. Completion 2022-01-24
Phase Phase 2

Sponsor

Janssen Research & Development

593 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02877134

The ClinicalTrials.gov registry entry for NCT02877134 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 388 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 200-participant average among 71 other Crohn Disease trials with a reported enrollment target (94% higher). The listed sponsor is Janssen Research & Development, which has 593 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Crohn Disease appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT02877134 reports 20 study locations spanning 9 distinct geographic areas - top geographies include Florida, New York, Louisiana.

Frequently Asked Questions

What is clinical trial NCT02877134 about?

NCT02877134 is a clinical study titled "Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease". The purpose of the study is to assess the safety and efficacy of JNJ-64304500 in participants with moderately to severely active Crohn's disease.

What is the current status of trial NCT02877134?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 388 participants. The study started on 2016-08-25. Estimated completion is 2022-01-24.

What conditions does trial NCT02877134 study?

This clinical trial studies the following conditions: Crohn Disease.

What interventions are being tested in trial NCT02877134?

The interventions under investigation include: Placebo (DRUG), Ustekinumab (DRUG), JNJ-64304500 (DRUG).

Who is sponsoring clinical trial NCT02877134?

This trial is sponsored by Janssen Research & Development, which has 593 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02877134 being conducted?

This trial has 20 study locations across Colorado, Florida, Georgia, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Crohn Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Crohn Disease

All registered trials for this condition

Colorado

All trials with a study site in Colorado

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.